Nektar Therapeutics DPO Ratio 2011-2026 | NKTR

Annual DPO Ratio Nektar Therapeutics

2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
123	192	234	388	328	87.5	57.1	34	25.3	34.6	86.4	34.3	50.3

All numbers in USD currency

Maximum	Minimum	Average
388	25.3	129

2022-Q4	2022-Q3	2022-Q2	2022-Q1	2021-Q4	2021-Q3	2021-Q2	2021-Q1	2020-Q4	2020-Q3	2020-Q2	2020-Q1	2019-Q4	2019-Q3	2019-Q2	2019-Q1	2018-Q4	2018-Q3	2018-Q2	2018-Q1	2017-Q4	2017-Q3	2017-Q2	2017-Q1	2016-Q4	2016-Q3	2016-Q2	2016-Q1	2015-Q4	2015-Q3	2015-Q2	2015-Q1	2014-Q4	2014-Q3	2014-Q2	2014-Q1	2013-Q4	2013-Q3	2013-Q2	2013-Q1	2012-Q4	2012-Q3	2012-Q2	2012-Q1	2011-Q4	2011-Q3	2011-Q2	2011-Q1
-	48.9	-	192	247	372	251	353	467	363	350	495	293	356	350	210	71.6	112	96.7	73	44.7	76.9	48.5	56.5	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-

All numbers in USD currency

Maximum	Minimum	Average
495	44.7	224

Issuer	DPO Ratio	Price	% 24h	Market Cap	Country
AgeX Therapeutics AGE	9.04 K	-	-10.17 %	$ 12.2 K	USA
I-Mab IMAB	2.24 K	-	-	$ 866 M	China
Midatech Pharma plc MTP	162	-	-18.52 %	$ 27.3 M	Britain
Alexion Pharmaceuticals, Inc. ALXN	78.2	-	-	$ 40.3 B	USA
Cerus Corporation CERS	242	$ 2.72	33.99 %	$ 518 M	USA
ACADIA Pharmaceuticals ACAD	75.2	$ 21.95	-2.23 %	$ 3.64 B	USA
Ayala Pharmaceuticals AYLA	2.21 K	-	-	$ 7.46 M	Israel
AstraZeneca PLC AZN	265	-	-	$ 96.9 B	Britain
Berkeley Lights BLI	135	-	-7.31 %	$ 87 M	USA
Advaxis ADXS	143 K	-	-9.65 %	$ 45.9 M	USA
Институт стволовых клеток человека ISKJ	115	-	-	-	Russia
Cardiff Oncology CRDF	406	$ 1.71	-1.16 %	$ 114 M	USA
Caladrius Biosciences CLBS	51.2	-	-16.75 %	$ 25.8 M	USA
Aeterna Zentaris AEZS	34.4 K	-	5.93 %	$ 314 M	Canada
Deciphera Pharmaceuticals DCPH	2.2 K	-	-	$ 2.18 B	USA
AIkido Pharma AIKI	1.92	-	1.93 %	$ 17.4 M	USA
Dynavax Technologies Corporation DVAX	52.8	-	-	$ 2.02 B	USA
Eiger BioPharmaceuticals EIGR	84.3 K	-	-9.21 %	$ 2.55 M	USA
Ampio Pharmaceuticals AMPE	2.85 K	-	-11.43 %	$ 502 K	USA
Evogene Ltd. EVGN	62.6	$ 0.81	3.33 %	$ 27.9 M	Israel